1. 1373. Activity of Ceftriaxone–Sulbactam–EDTA Against Multi-Drug-resistant A. baumannii, P. aeruginosa and Enterobacteriaceae Isolates (WHO Critical Priority Pathogens) Collected from Various Hospitals in India. (26th November 2018) Authors: Girotra, Ruchi; Pyasi, Anurag; Chaudhary, Manu; Patil, N S; Mir, Mohd Amin; Chaudhary, Saransh; Mandale, Pankaj Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1974. Ceftriaxone-Sulbactam-EDTA vs. Meropenem in PLEA (a Phase 3, Randomized, Double-Blind Trial): Outcomes by Baseline MIC in Adults With Complicated Urinary Tract Infections or Acute Pyelonephritis. (26th November 2018) Authors: Mandale, Pankaj; Mir, Mohd Amin; Chaudhary, Saransh; Chaudhary, Manu; Sood, Rajeev; Patil, N S; Narang, Salil; Pyasi, Anurag; Shameem, Mohammad Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1984. Ceftriaxone-Sulbactam-EDTA vs. Meropenem: Analysis of Failed Patients With Assessment of MIC Increases and Changes in Genotypic Profile in PLEA (a Phase 3, Randomized, Double-Blind Clinical Trial in Adults With Complicated Urinary Tract Infections or Acute Pyelonephritis). (26th November 2018) Authors: Mir, Mohd Amin; Chaudhary, Saransh; Chaudhary, Manu; Pyasi, Anurag; Patil, N S; Girotra, Ruchi; Narang, Salil; Fatima, Nazish Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗